CONTENTS
· Invitation
· Comments

· Faculty
· Scientific Agenda
· Continuing Medical Education
· Who Should Attend?
· Objectives
· Registration
· General Information
· Hotel
  Accommodations
· Organizer

Several options are available to companies interested in supporting this conference. For more information, please contact Imedex at +1 (770) 751 7332, or by email at cme@imedex.com.

 

 

 

 

 


    
Email this link to a friend Print this page

6 - 7 JUNE 2008
3rd Annual European Conference: Perspectives in Inflammatory Bowel Diseases

Prague, Czech Republic
Hilton Prague

Chairs:
Paul Rutgeerts, MD, PhD
University Hospital Gathuisberg
Leuven, Belgium

Richard P. MacDermott, MD
Albany Medical College
Albany, New York, United States

Local Chair:
Milan Lukas, MD, PhD
Charles University in Prague
Prague, Czech Republic

Organizing Committee:
Subrata Ghosh, MD, FRCP
Imperial College of Medicine
London, United Kingdom

Derek P. Jewell, DPhil, FRCP
University of Oxford
Oxford, United Kingdom

Pia Munkholm, MD
University of Copenhagen
Herlev, Denmark



Click here to register for this program

.
  I N V I T A T I O N .

Dear Colleague:

We are pleased to invite you to the 3rd Annual European Conference: Perspectives in Inflammatory Bowel Diseases. We are looking forward this year to continued growth and another exceptional educational meeting.

This meeting allows specialists in the inflammatory bowel diseases, leading gastroenterologists and practicing clinicians to interact, review the state of the art and share the newest advances in the multidisciplinary management of IBD. An expert faculty of leading clinicians and researchers will participate in the scientific program.

New this year, by popular request, expanded case-based clinical breakout sessions will provide valuable and practical take-home information relevant to your own practice. New debates will cover controversial issues in the management of patients with IBD.

We are certain that you will find this meeting to be informative and enjoyable. The charming city of Prague will offer many enjoyments outside conference hours. We look forward to seeing you in June!

Sincerely,
Richard P. MacDermott, MD
Paul Rutgeerts, MD, PhD
Chairs

Milan Lukas, MD, PhD
Local Chair

.
  C O M M E N T S .

Comments from past participants

“Excellent conference.  Really recommended.”

“Thanks a lot for a very informative conference. It opened my clinical approach to IBD”

“Excellent overviews and expert’s opinion”

“A nice mix of clinical useful information and talks on science, research, and future.”

“The best IBD conference that I have been to in a long time”

.
  F A C U L T Y .

Geert D'Haens, MD, PhD
Imelda GI Clinical Research Center
Bonheiden, Belgium

Andre D'Hoore, MD
University Hospital of Leuven
Leuven, Belgium

Subrata Ghosh, MD, FRCP
Imperial College of Medicine
London, United Kingdom

Derek P. Jewell, DPhil, FRCP
University of Oxford
Oxford, United Kingdom

Marc Lémann, MD, PhD
Hospital Saint Louis
Paris, France

Milan Lukáš, MD, PhD
Charles University in Prague
Prague, Czech Republic

Richard P. MacDermott, MD
Albany Medical College
Albany, New York, United States

Anthony I. Morris, MD, FRCP
Royal Liverpool University Hospital
Liverpool, United Kingdom

Pia Munkholm, MD
University of Copenhagen
Herlev, Denmark

Paul Rutgeerts, MD, PhD
University Hospital
Leuven, Belgium

Andreas Schreyer, MD
University Hospital Regensburg
Regensburg, Germany

Gert Van Assche, MD
University Hospital of Leuven
Leuven, Belgium

.
  S C I E N T I F I C   A G E N D A .

Friday, 6 June 2008

8:30
Welcome and Introduction
Paul Rutgeerts, MD, PhD and Richard P. MacDermott, MD

Session I: Current therapy of the outpatient with IBD
Moderator: Subrata Ghosh, MD, FRCP

8:40
Use of 5-ASA (mesalazine) in the outpatient with IBD
Milan Lukáš, MD, PhD

9:05
Use of steroids in the outpatient with IBD
Pia Munkholm, MD

9:30
Use of immunomodulators in the outpatient with IBD
Marc Lémann, MD, PhD

9:55
Use of biologics in the outpatient with IBD
Paul Rutgeerts, MD, PhD

10:20
Coffee break

Session II: Selected Topics in IBD I
Moderator: Derek P. Jewell, DPhil, FRCP

10:50
What the clinician should know about IBD genetics
Derek P. Jewell, DPhil, FRCP

11:15
What the clinician should know about the immune system in IBD
Richard P. MacDermott, MD

11:40
Major side effects of IBD therapies
Marc Lémann, MD, PhD

12:05
Advances in surgery in IBD
Andre D'Hoore, MD

12:30
Lunch break

Session III: Case based break out sessions

14:30
A. Extraintestinal manifestations of IBD
Derek P. Jewell, DPhil, FRCP

B. Challenging surgical problems in IBD
Andre D'Hoore, MD

C. Treatment of the outpatient with severe IBD
Richard P. MacDermott,MD

15:15
Coffee break

15:30
A. Extraintestinal manifestations of IBD
Derek P. Jewell, DPhil, FRCP

B.
Challenging surgical problems in IBD
Andre D'Hoore, MD

C. Treatment of the outpatient with severe IBD
Richard P. MacDermott,MD

16:15
Adjourn

Saturday, 7 June 2008

8:30
Welcome and Introduction
Paul Rutgeerts, MD, PhD and Richard P. MacDermott, MD

Session IV: Selected Topics in IBD II
Moderator: Paul Rutgeerts, MD, PhD

8:40
Use of colonoscopy and upper endoscopy in IBD
Anthony I. Morris, MD, FRCP

9:05
Advances in radiological imaging for IBD
Andreas Schreyer, MD

9:30
Does our current therapy change the natural history of IBD?
Pia Munkholm, MD

9:55
New horizons in the future treatment of IBD
Geert D’Haens, MD, PhD

10:20
Coffee break

Session V: Debates: Controversies in IBD
Moderator: Richard P. MacDermott, MD

Debate 1:
10:50
Pro: When starting biologics, stop immunomodulators
Subrata Ghosh, MD, FRCP

11:05
Con: When starting biologics, continue immunomodulators
Paul Rutgeerts, MD, PhD

11:20
Panel discussion

Debate 2:
11:40
Pro: Continue immunomodulators and biologics during pregnancy
Geert D’Haens, MD, PhD

11:55
Con: Discontinue immunomodulators and biologics during pregnancy
Gert Van Assche, MD

12:10
Panel discussion

12:30
Lunch break

Session VI: Case based break out sessions

14:30
A. Cancer surveillance in Crohn’s disease and ulcerative colitis: What should we do about low grade dysplasia, polyps and DALM Lesions
Anthony I. Morris, MD, FRCP

B. Irritable Bowel Syndrome in the outpatient with IBD
Richard P. MacDermott, MD

C. Treatment of the inpatient with severe IBD
Gert Van Assche, MD

15:15
Coffee break

15:30
A. Cancer surveillance in Crohn’s disease and ulcerative colitis: What should we do about low grade dysplasia, polyps and DALM Lesions
Anthony I. Morris, MD, FRCP

B. Irritable bowel syndrome in the outpatient with IBD
Richard P. MacDermott, MD

C. Treatment of the inpatient with severe IBD
Gert Van Assche, MD

16:15
Adjourn

.
  C O N T I N U I N G  M E D I C A L  E D U C A T I O N .

Imedex, LLC is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uemd.be.

.
  W H O   S H O U L D   A T T E N D ? .

This activity is intended for gastroenterologists, radiologists, pathologists, surgeons, general physicians, trainees, clinical researchers, and other persons in the healthcare community with an interest in the treatment and management of patients with inflammatory bowel disease (IBD).

.
  O B J E C T I V E S .

After successfully completing this educational activity, participants should be able to:

  • Demonstrate thorough knowledge and clinical understanding of current and emerging therapies to manage both the in- and out-patient with IBD
  • Review the recent advances in the diagnosis and treatment of pediatric patients with IBD
  • Discuss the role of surgery and potential surgical complications in patients with IBD
  • Summarize current strategies to prevent, diagnose, and treat infectious complications of IBD
  • Evaluate the use of colonoscopy, upper endoscopy, and radiological imaging techniques to diagnose and manage IBD
  • Debate the timing and combination of biologics and immunomodulators for the treatment of IBD, particularly during pregnancy
  • Assess the prognostic importance of detecting dysplasia and/or polyps during cancer surveillance in patients with IBD

.

  R E G I S T R A T I O N .

Click here to register for this program

REGISTRATION FEES

Regular . . . . . . . . . . . . . . . . . . € 399
payment received by 29 May 2008

Full/Onsite: . . . . . . . . . . . . . . . € 499
payment received after 29 May 2008

Nurses/Residents/Students*. . . . € 200
*proof of eligibility must accompany registration

To Register: You may register online by 29 May 2008 or by calling Imedex at +1 (678) 242 0906. Registration confirmations will be issued before the meeting.

To qualify for special registration fees, registration and full payment must be received by Imedex by the dates specified.

Payment: To pre-register, registration and payment must be received no later than 29 May 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the course is being held as scheduled and to confirm that the meeting is not full. Registration fees must be remitted by credit card, check, or wire transfer. Checks should be payable to Imedex. To pay via wire transfer, you must add e50 to each wire transaction to cover bank charges. Include the full name of the attendee and the name of the conference: 3rd Annual European Conference: Perspectives in IBD 319. An attendee is not registered until full payment is received.

Wire to: Bank of America, NA London, 1 Alie Street E1ADE London UK, Swift Code: BOFAGB22, Sort Code: 165050 Beneficiary: Bank of America Domestic Deposit #5687, Account #: 600895687029, Reference: Imedex, Inc. Account # 10726-118, IBAN: GB89 BOFA 1650 5095 6870 29.

Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.

Cancellation: For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 29 May 2008. The amount of registration fees remitted, minus a € 90 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after 29 May 2008. Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.

.
  G E N E R A L   I N F O R M A T I O N .

CONFERENCE LOCATION
Hilton Prague
Pobrezni 1
186 00 Prague 8
Czech Republic 
Tel: 420-224-841-111 
Fax: 420-224-842-378
www.prague.hilton.com

The Registration and Information Desk at the Hilton Prague will be staffed:
Friday, 6 June 2008 . . . . . . . . . 8:00 – 15:45
Saturday, 7 June 2008 . . . . . . . 7:00 – 15:45

DISCOUNTED AIRFARES
Contact conference travel agent, Williamsburg Travel, for assistance with your travel needs. Williamsburg Travel can also accommodate pre- and post-conference extensions.

Tel.: +1 (800) 523 4954 or +1 (404) 591 7120
Email: judit@willtrav.com

Important Dates
Regular Registration Deadline . . . . . . 29 May 2008

.
  H O T E L   A C C O M M O D A T I O N S .

Hilton Prague
Pobrezni 1
186 00 Prague 8
Czech Republic 
Tel: 420 224 841 111 
Fax: 420 224 842 378
www.prague.hilton.com

The Hilton Prague hotel was voted the second Best Business Hotel in Eastern Europe by the Business Traveler Magazine in 2006.

Overlooking the River Vltava, the Hilton Prague hotel offers one of Europe’s largest conference facilities.

From Hilton Guest Rooms to Executive Rooms with Executive Lounge access, all Hilton Prague hotel rooms have high-speed internet access. Executive Rooms offer wireless internet access.

Explore Prague attractions from the Hilton Prague hotel, located close to the city center. Savor Czech specialties at CzecHouse Grill & Rotisserie at the Hilton Prague hotel.

For the convenience of attendees, a limited number of rooms have been reserved until 15 May 2008 at a discounted rate of € 205 for single occupancy and € 220 for double occupancy, plus VAT, currently at 9%. This rate is not guaranteed outside the conference dates or after 5 April 2008. The rate includes a breakfast buffet daily.

To reserve your room please contact the Hilton Prague reservations department at 420-224-841-111 or you may register using the hotel reservation form which is located here. To receive the group rate, callers must identify themselves as being with the European IBD group. Reservation requests received after 15 May 2008 may not be guaranteed the group rate.

.
  O R G A N I Z E R .

.
          4325 Alexander Drive
          Alpharetta, GA 30022-3740 USA

          Tel.: +1 (770) 751 7332
          Fax: +1 (770) 751 7334
          Email: meetings@imedex.com
          Web: www.imedex.com

© 2008 Imedex®, LLC